Expects FY23 operating expenses to be below FY22, and free cash outflow to be approximately $350M.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GH:
- Guardant Health Earnings Update: Did it Beat Estimate Forecasts?
- Guardant Health options imply 7.3% move in share price post-earnings
- Guardant Health initiates new Shield study
- Guardant Health gets coverage from UHC for Guardant360 in lung, breast cancer
- Guardant Health, AnHeart Therapeutics team on NSLC companion diagnostics